STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer
STRATEGIC-1：一项针对不可切除的 RAS/BRAF 野生型转移性结直肠癌的多线、随机、开放标签的 GERCOR-PRODIGE-39 III 期试验
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-026-02639-y
Chibaudel, Benoist; Dourthe, Louis-Marie; André, Thierry; Henriques, Julie; Bourgeois, Vincent; Etienne, Pierre-Luc; Desramé, Jérôme; Carola, Elisabeth; Dupuis, Olivier; Baba-Hamed, Nabil; Auby, Dominique; Louvet, Christophe; Maillard, Emmanuel; Romano, Olivier; Tournigand, Christophe; Garcia-Larnicol, Marie-Line; Shacham-Shmueli, Einat; Bird, Brian Healey; Ghiringhelli, François; de Gramont, Aimery
